Effect of multi-glycosides of tripterygii on latent autoimmune diabetes in adults in early stage.
- Author:
Tao LEI
1
;
Xiu-zhen ZHANG
;
Ming HE
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Age of Onset; Autoantibodies; Autoimmune Diseases; drug therapy; Diabetes Mellitus, Type 1; classification; drug therapy; Drug Therapy, Combination; Female; Glycosides; therapeutic use; Humans; Immunosuppressive Agents; therapeutic use; Insulin; therapeutic use; Male; Middle Aged; Phytotherapy; Time Factors; Tripterygium; chemistry
- From: Chinese Journal of Integrated Traditional and Western Medicine 2006;26(6):511-513
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the effect of multi-glycosides of tripterygii (MT) on latent autoimmune diabetes of adults (LADA) in early stage.
METHODSThe diabetic patients were divided randomly into the control group treated with insulin alone and the treated group treated with insulin and MT. Levels of insulin, C-peptide, glutamic acid decarboxylase antibody (GADAb) and islet cell antibody (ICA) were detected and clinical features of the disease were observed.
RESULTSThere was no difference between the control group and the treated group in body mass index (BMI), the occurrence of diabetic keto-acidosis and the function of liver and kidney (P >0.05). After 6 months' treatment, the positive rate of GADAb and ICA decreased, plasma levels of fasting and 2 hrs post-prandial C-peptide and also 2 hrs post-prandial true insulin in the treated group increased (P <0.01), while all the above indexes improved more significantly after 1 year's treatment (P <0.01).
CONCLUSIONCompared treatment of insulin with multi-glycosides of tripterygii in early stage of LADA has better effects in relieving autoimmune injury and recovering function of pancreatic island than insulin alone.
